Literature DB >> 10980530

Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.

K Laake1, L Jansen, J M Hahnemann, K Brondum-Nielsen, T Lönnqvist, H Kääriäinen, R Sankila, A Lähdesmäki, L Hammarström, J Yuen, S Tretli, A Heiberg, J H Olsen, M Tucker, R Kleinerman, A L Børresen-Dale.   

Abstract

The Ataxia Telangiectasia Mutation (ATM) gene is mutated in the rare recessive syndrome Ataxia Telangiectasia (AT), which is characterized by cerebellar degeneration, immunodeficiency, and cancer predisposition. In this study, 41 AT families from Denmark, Finland, Norway, and Sweden were screened for ATM mutations. The protein truncation test (PTT), fragment length and heteroduplex analyses of large (0.8-1.2 kb) cDNA fragments were used. In total, 67 of 82 (82%) of the disease-causing alleles were characterized. Thirty-seven unique mutations were detected of which 25 have not previously been reported. The mutations had five different consequences for the ATM transcript: mutations affecting splicing (43%); frameshift mutations (32%); nonsense mutations (16%); small in-frame deletions (5%); and one double substitution (3%). In 28 of the probands mutations were found in both alleles, in 11 of the probands only one mutated allele was detected, and no mutations were detected in two Finnish probands. One-third of the probands (13) were homozygous, whereas the majority of the probands (26) were compound heterozygote with at least one identified allele. Ten alleles were found more than once; one Norwegian founder mutation constituted 57% of the Norwegian alleles. Several sequence variants were identified, none of them likely to be disease-causing. Some of them even involved partial skipping of exons, leading to subsequent truncation of the ATM protein. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10980530     DOI: 10.1002/1098-1004(200009)16:3<232::AID-HUMU6>3.0.CO;2-L

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.

Authors:  Yingli Sun; Xiaofeng Jiang; Shujuan Chen; Norvin Fernandes; Brendan D Price
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

3.  TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.

Authors:  G Maydan; B S Andresen; P P Madsen; M Zeigler; A Raas-Rothschild; A Zlotogorski; A Gutman; S H Korman
Journal:  J Inherit Metab Dis       Date:  2006-08-17       Impact factor: 4.982

4.  Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.

Authors:  Margot A Cousin; Matthew J Smith; Ashley N Sigafoos; Jay J Jin; Marine I Murphree; Nicole J Boczek; Patrick R Blackburn; Gavin R Oliver; Ross A Aleff; Karl J Clark; Eric D Wieben; Avni Y Joshi; Pavel N Pichurin; Roshini S Abraham; Eric W Klee
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

5.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Identification of a novel nonsynonymous mutation of EYA1 disrupting splice site in a Korean patient with BOR syndrome.

Authors:  Hui Ram Kim; Mee Hyun Song; Min-A Kim; Ye-Ri Kim; Kyu-Yup Lee; Jong Kyung Sonn; Jaetae Lee; Jae Young Choi; Un-Kyung Kim
Journal:  Mol Biol Rep       Date:  2014-03-04       Impact factor: 2.316

7.  Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

Authors:  M Mitui; S A Nahas; L T Du; Z Yang; C H Lai; K Nakamura; S Arroyo; S Scott; A Purayidom; P Concannon; M Lavin; R A Gatti
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

8.  ATM variants and cancer risk in breast cancer patients from Southern Finland.

Authors:  Johanna Tommiska; Laila Jansen; Outi Kilpivaara; Hege Edvardsen; Vessela Kristensen; Anitta Tamminen; Kristiina Aittomäki; Carl Blomqvist; Anne-Lise Børresen-Dale; Heli Nevanlinna
Journal:  BMC Cancer       Date:  2006-08-16       Impact factor: 4.430

9.  ATM haplotypes and breast cancer risk in Jewish high-risk women.

Authors:  M Koren; G Kimmel; E Ben-Asher; I Gal; M Z Papa; J S Beckmann; D Lancet; R Shamir; E Friedman
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

10.  Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.

Authors:  J H Olsen; J M D Hahnemann; A-L Børresen-Dale; S Tretli; R Kleinerman; R Sankila; L Hammarström; T E Robsahm; H Kääriäinen; A Bregård; K Brøndum-Nielsen; J Yuen; M Tucker
Journal:  Br J Cancer       Date:  2005-07-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.